[Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases E. Vilarrasa; J. Nicolau; P. de la Cueva; A. Goday; F. Gallardo; A. Martorell-Calatayud; J.M. Carrascosa;

Agonistas del receptor de GLP-1 para el tratamiento de la obesidad en pacientes con dermatosis inmunomediadas E. Vilarrasa; J. Nicolau; P. de la Cueva; A. Goday; F. Gallardo; A. Martorell; J.M. Carrascosa;

Psoriasis Severity, Health-Related Quality of Life, Work Productivity, and Activity Impairments Among Patients With Moderate to Severe Psoriasis Receiving Systemic Treatment: Real-World Data From Clinical Practice in Spain E. Daudén; D. Vidal; A. Romero; M.T. Bordel; R. Rivera; J. Márquez; E. Zamora; L. Martinez; M.J. Ocaña; C. Vila; P. Iribarren; N. Corona; A. Zulaica;